Terms: = Breast cancer AND MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7
1199 results:
1. Decoding the Versatile Landscape of Autophagic Protein VMP1 in cancer: A Comprehensive Review across Tissue Types and Regulatory Mechanisms.
Renna FJ; Gonzalez CD; Vaccaro MI
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612567
[TBL] [Abstract] [Full Text] [Related]
2. Noducyclamides A1-A4, B1, and B2 from the Cyanobacterium
Mehjabin JJ; Phan CS; Okino T
J Nat Prod; 2024 Apr; 87(4):984-993. PubMed ID: 38587271
[TBL] [Abstract] [Full Text] [Related]
3. Discovery of ganoderic acid A (GAA) PROTACs as MDM2 protein degraders for the treatment of breast cancer.
Li Y; Li G; Zuo C; Wang X; Han F; Jia Y; Shang H; Tian Y
Eur J Med Chem; 2024 Apr; 270():116367. PubMed ID: 38581732
[TBL] [Abstract] [Full Text] [Related]
4. BRCA1 deficiency enhances the aggressiveness of breast cancer cells expressing HPV16 oncoproteins.
Sangthong J; Thuwajit C; Jensen LT; Komyod W; Yuvaniyama J; Ponglikitmongkol M
Biol Cell; 2024 Apr; 116(4):e202300072. PubMed ID: 38514439
[TBL] [Abstract] [Full Text] [Related]
5. Integrating single-cell and spatial transcriptomes reveals COL4A1/2 facilitates the spatial organisation of stromal cells differentiation in breast phyllodes tumours.
Li X; Yu X; Bi J; Jiang X; Zhang L; Li Z; Shao M
Clin Transl Med; 2024 Mar; 14(3):e1611. PubMed ID: 38481388
[TBL] [Abstract] [Full Text] [Related]
6. breast composition during and after puberty: the Chilean Growth and Obesity Cohort Study.
Pereira A; Garmendia ML; Leiva V; Corvalán C; Michels KB; Shepherd J
Breast Cancer Res; 2024 Mar; 26(1):45. PubMed ID: 38475816
[TBL] [Abstract] [Full Text] [Related]
7. Clinical Relevance of Tumour-Infiltrating Immune Cells in HER2-Negative breast cancer Treated with Neoadjuvant Therapy.
Arqueros C; Gallardo A; Vidal S; Osuna-Gómez R; Tibau A; Lidia Bell O; Ramón Y Cajal T; Lerma E; Lobato-Delgado B; Salazar J; Barnadas A
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473874
[TBL] [Abstract] [Full Text] [Related]
8. Telocinobufagin, a PLK1 suppressor that inhibits tumor growth and metastasis by modulating CDC25c and CTCF in HNSCC cells.
Li J; Ma R; Lv JL; Ren YS; Tan YJ; Wang HM; Wang ZE; Wang BS; Yu JN; Wang YL; Tian J; Zheng QS
Phytomedicine; 2024 May; 127():155440. PubMed ID: 38452691
[TBL] [Abstract] [Full Text] [Related]
9. Triple-negative breast cancer survival prediction using artificial intelligence through integrated analysis of tertiary lymphoid structures and tumor budding.
Hou X; Li X; Han Y; Xu H; Xie Y; Zhou T; Xue T; Qian X; Li J; Wang HC; Yan J; Guo X; Liu Y; Liu J
Cancer; 2024 Apr; 130(S8):1499-1512. PubMed ID: 38422056
[TBL] [Abstract] [Full Text] [Related]
10. LncRNA CHROMR/miR-27b-3p/MET axis promotes the proliferation, invasion, and contributes to rituximab resistance in diffuse large B-cell lymphoma.
Liu C; Zhao X; Wang Z; Zhang C; Zheng W; Zhu X; Zhang D; Gong T; Zhao H; Li F; Guan T; Guo X; Zhang H; Yu B
J Biol Chem; 2024 Mar; 300(3):105762. PubMed ID: 38367665
[TBL] [Abstract] [Full Text] [Related]
11. Single-cell sequencing reveals the immune landscape of breast cancer patients with brain metastasis.
Zhou H; He X; Huang J; Zhong Y; Zhang L; Ao X; Zhao H; Hu S; Li H; Huang J; Huang H; Liang H
Thorac Cancer; 2024 Mar; 15(9):702-714. PubMed ID: 38316626
[TBL] [Abstract] [Full Text] [Related]
12. Long-term outcomes with HLX01 (HanliKang
Qin Y; Song Y; Wang D; Bai O; Feng J; Sun X; Qiu L; Yang J; Yang Y; Wang Z; Hu J; Wang H; Su H; Jin Z; Qian W; Jin C; Zhang M; Yu D; Liu L; Chen G; Li Y; Sun T; Jin J; Bao H; Du X; Zhou H; Fu G; Shi Y
BMC Cancer; 2024 Jan; 24(1):124. PubMed ID: 38267866
[TBL] [Abstract] [Full Text] [Related]
13. Therapy-induced senescent cancer cells exhibit complement activation and increased complement regulatory protein expression.
Abu-Humaidan AH; Ismail MA; Ahmad FM; Al Shboul S; Barham R; Tadros JS; Alhesa A; El-Sadoni M; Alotaibi MR; Ababneh NA; Saleh T
Immunol Cell Biol; 2024 Apr; 102(4):240-255. PubMed ID: 38265162
[TBL] [Abstract] [Full Text] [Related]
14. New Rare Triterpene Glycosides from Pacific Sun Star,
Malyarenko TV; Kicha AA; Kuzmich AS; Malyarenko OS; Kalinovsky AI; Popov RS; Dmitrenok PS; Ivanchina NV; Stonik VA
Mar Drugs; 2023 Dec; 22(1):. PubMed ID: 38248644
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic value of cyclin B1 and cyclin B2 expression in breast cancer: A systematic review and updated meta-analysis.
Kang J; Jung H; Kim H
Medicine (Baltimore); 2024 Jan; 103(3):e37016. PubMed ID: 38241547
[TBL] [Abstract] [Full Text] [Related]
16. Prognostic value and distribution pattern of tumor infiltrating lymphocytes and their subsets in distant metastases of advanced breast cancer.
Sun XY; Wang CQ; Mao Y; Zhang ZQ; Cui J; Dong XN; Wang HB
Clin Breast Cancer; 2024 Apr; 24(3):e167-e176. PubMed ID: 38212189
[TBL] [Abstract] [Full Text] [Related]
17. Efficacy, safety, and prognosis prediction in patients treated with ribociclib in combination with letrozole: Final results of phase 3b RIBECCA study in hormone receptor positive, human epidermal growth factor receptor-2 negative, locally advanced or metastatic breast cancer.
Fasching PA; Decker T; Hartkopf A; Nusch A; Heinrich BJ; Kurbacher C; Fuchs R; Tesch H; Krabisch P; Huober J; Kuemmel S; Brucker S; Janni W; Schneeweiss A; Schuler M; Fehm T; Lüftner D; Quiering C; Voges C; Kreuzeder J; Reinisch M
Eur J Cancer; 2024 Feb; 198():113480. PubMed ID: 38154393
[TBL] [Abstract] [Full Text] [Related]
18. Impact of Mutations in Subunit Genes of the Mammalian SWI/SNF Complex on Immunological Tumor Microenvironment.
Hozumi C; Iizuka A; Ikeya T; Miyata H; Maeda C; Ashizawa T; Nagashima T; Urakami K; Shimoda Y; Ohshima K; Muramatsu K; Sugino T; Shiomi A; Ohde Y; Bando E; Furukawa K; Sugiura T; Mukaigawa T; Nishimura S; Hirashima Y; Mitsuya K; Yoshikawa S; Tsubosa Y; Katagiri H; Niwakawa M; Yamaguchi K; Kenmotsu H; Akiyama Y
Cancer Genomics Proteomics; 2024; 21(1):88-101. PubMed ID: 38151294
[TBL] [Abstract] [Full Text] [Related]
19. Inhibition of Drp1 orchestrates the responsiveness of breast cancer cells to paclitaxel but insignificantly relieves paclitaxel-related ovarian damage in mice.
Alalawy AI; Sakran M; Alzuaibr FM; Alotaibi MA; El-Hefnawy ME; Hazazi AY; El-Gendy SM; Aidy EA; Effat H; Ismail DF; Hessien M
Sci Rep; 2023 Dec; 13(1):22782. PubMed ID: 38129495
[TBL] [Abstract] [Full Text] [Related]
20. Prevalent landscape of tumor genomic alterations of luminal B1 breast cancers using a comprehensive genomic profiling assay in Taiwan.
Chen BF; Tsai YF; Lien PJ; Lin YS; Feng CJ; Chen YJ; Cheng HF; Liu CY; Chao TC; Lai JI; Tseng LM; Huang CC
Breast Cancer; 2024 Mar; 31(2):217-227. PubMed ID: 38070067
[TBL] [Abstract] [Full Text] [Related]
[Next]
